Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
 Moves Forward With Uplifting Requirements for OTCQB, Aggressively Pursues Take Over Targets - EconoTimes)
VIRGINIA BEACH, Va., Oct. 18, 2017 -- BioForce Nanosciences Holdings, Inc. (OTCPINK:BFNH) announces its pursuit to uplift the Company’s tradable common shares onto the OTCQB at OTCMARKETS.COM.
The Company hired new accountants, PCAOB auditors and a securities law firm to assist on the necessary financial disclosures and other related requirements for uplift, OTCQB.
During the last few quarters of operations, BFNH’s management team aggressively looked at a number of unique businesses operations with acquisition intentions. Due diligence continues on these acquisition “targets” and management believes at least one or more can be acquired.
BFNH management looks at the each target with specific comprehensible modeling, not just limited to goods and services, but includes competition, patents, domestic/international demographics, demand of products/services, outstanding debts/liabilities and other business transparencies.
BFNH will provide more information as the deal-flow becomes more mature.
For further information about this release, contact YES INTERNATIONAL, Investor Relations, 757-306-6090, [email protected] and www.yesinternational.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain forward information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competitions.
CONTACT: BioForce Nanosciences Holdings, Inc.
Rich Kaiser, 757-306-6090
